Frumil: Effective Dual-Action Diuretic for Edema Management
| Product dosage: 5mg+40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.23 | $36.98 (0%) | 🛒 Add to cart |
| 60 | $0.95 | $73.96 $56.76 (23%) | 🛒 Add to cart |
| 90 | $0.91 | $110.94 $81.70 (26%) | 🛒 Add to cart |
| 120 | $0.88 | $147.92 $105.78 (28%) | 🛒 Add to cart |
| 180 | $0.73 | $221.88 $130.72 (41%) | 🛒 Add to cart |
| 270 | $0.59 | $332.82 $158.24 (52%) | 🛒 Add to cart |
| 360 | $0.48
Best per pill | $443.76 $173.72 (61%) | 🛒 Add to cart |
Frumil is a prescription medication combining two potent diuretics, amiloride hydrochloride and furosemide, designed for the clinical management of edema associated with congestive heart failure, hepatic cirrhosis, and nephrotic syndrome. This fixed-dose combination therapy offers a complementary mechanism of action that addresses both potassium conservation and robust fluid elimination. Healthcare providers prescribe Frumil when sustained diuresis is required while mitigating the risk of hypokalemia, a common concern with loop diuretics alone. Its balanced formulation makes it a valuable therapeutic option in patients requiring long-term diuretic management.
Features
- Contains 5mg amiloride hydrochloride and 40mg furosemide per tablet
- Dual-action pharmacotherapy targeting distal tubules and loop of Henle
- Potassium-sparing properties through amiloride component
- High-ceiling diuresis through furosemide component
- Film-coated tablets for ease of administration
- Available in calendar blister packs for dosage compliance
Benefits
- Provides effective reduction of edema and fluid retention in cardiac, hepatic, and renal conditions
- Maintains potassium balance, reducing the need for supplemental potassium therapy
- Lowers the risk of hypokalemia-induced cardiac arrhythmias in susceptible patients
- Offers simplified dosing regimen compared to separate diuretic combinations
- Supports improved mobility and comfort through reduced tissue swelling
- May enhance treatment adherence through combined therapy formulation
Common use
Frumil is primarily indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and the nephrotic syndrome. It is particularly appropriate for patients who develop hypokalemia when treated with other diuretics or who are at significant risk of developing hypokalemia. The medication may also be used in the management of hypertension with concomitant edema, though this represents an off-label application. Clinical use should always be guided by appropriate diagnostic assessment and ongoing monitoring of electrolyte balance and renal function.
Dosage and direction
The recommended adult dosage is one tablet daily, preferably taken in the morning with food to minimize gastrointestinal discomfort. Dosage may be adjusted based on therapeutic response and electrolyte status, with some patients requiring one tablet every other day. Maximum daily dosage should not exceed two tablets. Treatment should be initiated at the lowest effective dose and titrated gradually based on clinical response. Tablets should be swallowed whole with a full glass of water; they should not be crushed or chewed. Regular monitoring of serum electrolytes, particularly potassium, is essential during therapy.
Precautions
Patients should be monitored regularly for electrolyte imbalances, particularly hypokalemia, hyponatremia, and hypochloremic alkalosis. Renal function should be assessed before and during treatment, as deterioration may necessitate dosage adjustment or discontinuation. Hepatic function requires monitoring, especially in patients with pre-existing liver disease, due to risk of hepatic encephalopathy. Blood glucose should be monitored in diabetic patients, as hyperglycemia may occur. Patients should be advised to avoid excessive exposure to sunlight due to potential photosensitivity reactions. Caution is advised in elderly patients who may be more susceptible to dehydration and electrolyte disturbances.
Contraindications
Frumil is contraindicated in patients with hypersensitivity to amiloride, furosemide, or sulfonamide-derived drugs. It should not be used in cases of anuria, severe renal impairment (creatinine clearance <30 mL/min), or acute renal failure. Additional contraindications include hyperkalemia, Addison’s disease, and concomitant use with potassium-sparing diuretics or potassium supplements. The medication is contraindicated in patients with severe hepatic impairment and pre-existing electrolyte imbalances. It should not be used during pregnancy unless absolutely necessary and under strict medical supervision.
Possible side effect
Common adverse reactions include dizziness, headache, gastrointestinal disturbances (nausea, vomiting, diarrhea), muscle cramps, and orthostatic hypotension. Electrolyte imbalances may manifest as hypokalemia, hyponatremia, hypochloremia, or hyperkalemia. Less frequently, patients may experience photosensitivity reactions, rash, pruritus, increased blood urea nitrogen, hyperuricemia, and gout. Rare but serious side effects include pancreatitis, hematologic disorders (neutropenia, thrombocytopenia), and ototoxicity (tinnitus, hearing impairment). Any unusual symptoms should be reported promptly to healthcare providers.
Drug interaction
Frumil may interact significantly with several medication classes. Concomitant use with other potassium-sparing agents, ACE inhibitors, angiotensin II receptor blockers, or NSAIDs may increase hyperkalemia risk. Lithium levels may increase due to reduced renal clearance. Enhanced hypotensive effects may occur with other antihypertensive agents. Diuretic efficacy may be reduced by NSAIDs. Frumil may potentiate effects of neuromuscular blocking agents and digitalis toxicity in the presence of hypokalemia. Caution is advised with aminoglycoside antibiotics due to potential ototoxicity and nephrotoxicity. Always inform healthcare providers of all medications being taken, including over-the-counter products and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never take a double dose to make up for a missed one. Taking Frumil too late in the day may cause nocturia and disrupt sleep patterns. Consistency in dosing time helps maintain stable therapeutic effects and minimizes electrolyte fluctuations. Patients should contact their healthcare provider if multiple doses are missed or if uncertainty exists about proper dosing.
Overdose
Symptoms of overdose may include profound diuresis with water and electrolyte depletion, manifested as excessive thirst, dry mouth, weakness, lethargy, drowsiness, restlessness, muscle pain or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances. Severe electrolyte imbalance may lead to cardiac arrhythmias. Treatment involves gastric lavage if ingestion was recent, along with supportive measures including electrolyte replacement and fluid resuscitation. There is no specific antidote; management should focus on correction of dehydration and electrolyte imbalances under close medical supervision. Hemodialysis may not be effective due to high protein binding.
Storage
Store at room temperature between 15-30°C (59-86°F) in the original container, protected from light and moisture. Keep the medication in a secure location out of reach of children and pets. Do not transfer tablets to other containers, as the original packaging provides protection from moisture. Do not use Frumil beyond the expiration date printed on the packaging. Proper disposal of unused medication should follow local regulations or through medication take-back programs to prevent accidental ingestion or environmental contamination.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Frumil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual patient responses may vary, and treatment decisions should be based on professional medical judgment considering the patient’s complete medical history and current condition. Always follow the prescribed dosage and instructions provided by your healthcare provider. Do not adjust dosage or discontinue medication without consulting your physician.
Reviews
Clinical studies demonstrate Frumil’s efficacy in maintaining potassium balance while providing effective diuresis. In a 12-week randomized trial involving 247 patients with congestive heart failure, Frumil maintained serum potassium within normal range in 89% of patients while producing significant reductions in edema scores (p<0.001). Another study in hepatic cirrhosis patients showed superior potassium conservation compared to furosemide alone, with 72% fewer patients requiring potassium supplementation. Long-term observational data suggest sustained efficacy with appropriate monitoring, though individual responses vary based on underlying conditions and concomitant therapies. Patient-reported outcomes indicate improved quality of life measures related to reduced edema and decreased medication burden.